Combined immunodeficiency due to CD3gamma deficiency

Combined immunodeficiency due to CD3gamma deficiency is an extremely rare inherited primary immunodeficiency disorder caused by mutations in the CD3G gene, which encodes the CD3 gamma chain, a critical component of the T-cell receptor (TCR) complex. The CD3 gamma chain is essential for proper assembly, surface expression, and signaling of the TCR on T lymphocytes. When this protein is absent or dysfunctional, T-cell development and function are impaired, leading to a combined immunodeficiency that primarily affects the immune system. Patients with this condition typically present in early childhood with recurrent and severe infections, including bacterial, viral, and opportunistic infections. The clinical severity can be variable, ranging from a severe combined immunodeficiency (SCID)-like phenotype with life-threatening infections in infancy to a milder combined immunodeficiency with susceptibility to infections and autoimmune manifestations. Affected individuals may exhibit reduced numbers of T cells or T cells with impaired function, while B-cell and natural killer cell numbers may be relatively preserved, though antibody responses can be compromised due to defective T-cell help. Treatment depends on the severity of the immunodeficiency. Supportive care includes prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy to reduce the burden of infections. For patients with severe disease, hematopoietic stem cell transplantation (HSCT) represents the only curative option and can restore immune function when performed early. Careful monitoring for autoimmune complications is also important in the management of these patients.

Common questions about Combined immunodeficiency due to CD3gamma deficiency